6-((1R,2S,5S)-2-Benzyl-3-azabicyclo[3.1.0]hexan-3-yl)-4-morpholinopyridin-2(1H)-one

ID: ALA4874640

PubChem CID: 156458424

Max Phase: Preclinical

Molecular Formula: C21H25N3O2

Molecular Weight: 351.45

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1cc(N2CCOCC2)cc(N2C[C@H]3C[C@H]3[C@@H]2Cc2ccccc2)[nH]1

Standard InChI:  InChI=1S/C21H25N3O2/c25-21-13-17(23-6-8-26-9-7-23)12-20(22-21)24-14-16-11-18(16)19(24)10-15-4-2-1-3-5-15/h1-5,12-13,16,18-19H,6-11,14H2,(H,22,25)/t16-,18-,19+/m1/s1

Standard InChI Key:  FZLLSBHPQYLGLH-QRQLOZEOSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   32.1181   -1.2959    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.1181   -2.1173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8275   -2.5259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5369   -2.1173    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5369   -1.2959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8275   -0.8832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2477   -2.5299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2446   -3.3522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9476   -3.7617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6624   -3.3576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6656   -2.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9539   -2.1171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9423   -4.5789    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.3756   -2.1308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.1184   -2.4652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4639   -1.3164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2843   -3.2654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0602   -3.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2245   -4.3221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9996   -4.5786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6105   -4.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4412   -3.2308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6662   -2.9780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2641   -1.1510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6664   -1.8578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0774   -1.1560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3708   -2.2658    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   37.2565   -0.3302    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  4  7  1  0
  9 13  2  0
 11 14  1  0
 14 15  1  0
 15 25  1  0
 24 16  1  0
 16 14  1  0
 15 17  1  6
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 25 24  1  0
 25 26  1  0
 24 26  1  0
 25 27  1  6
 24 28  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4874640

    ---

Associated Targets(Human)

ATM Tchem Serine-protein kinase ATM (4198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3C3 Tchem Phosphatidylinositol 3-kinase catalytic subunit type 3 (535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKDC Tchem DNA-dependent protein kinase (1929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATR Tchem Serine-protein kinase ATR (986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 351.45Molecular Weight (Monoisotopic): 351.1947AlogP: 2.28#Rotatable Bonds: 4
Polar Surface Area: 48.57Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.86CX Basic pKa: 5.02CX LogP: 2.19CX LogD: 2.19
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.92Np Likeness Score: -0.24

References

1. Van de Poël A, Toledo-Sherman L, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Peacock M, Barnard A, Cox HC, Jones G, McAllister G, Vater H, Esmieu W, Clissold C, Lamers M, Leonard P, Jarvis RE, Blackaby W, Eznarriaga M, Lazari O, Yates D, Rose M, Jang SW, Muñoz-Sanjuan I, Dominguez C..  (2021)  Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease.,  64  (8.0): [PMID:33783225] [10.1021/acs.jmedchem.1c00114]

Source